In other countries
The same active substances on other registers, the same brand first.
- MayzentEuropean Union · Novartis Europharm LimitedSame brand
- MayzentCroatiaSame brand
- MayzentItaly · Compressa rivestita con film · Novartis Europharm LimitedSame brand
- Mayzent 0,25 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Novartis Europharm LimitedSame brand
- Mayzent 1 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Novartis Europharm LimitedSame brand
- Mayzent 2 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Novartis Europharm LimitedSame brand
- MAYZENT 0.25mgRomania · 0.25mg · compr. film. · Novartis Europharm LimitedSame brand
- MAYZENT 2mgRomania · 2mg · compr. film. · Novartis Europharm LimitedSame brand
- Mayzent®Serbia · 0.25mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- Mayzent®Serbia · 1mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- Mayzent®Serbia · 1mg · film tableta · PredstavniŠTvo Novartis Pharma Services INC. Beograd (Novi Beograd)Same brand
- MayzentSaudi Arabia · NOVARTIS Pharma Stein AGSame brand
- MayzentUnited States · 0.25MG BASE, 1MG BASE, 2MG BASE · tablet · NovartisSame brand
- SiponimodUnited States · 0.25MG, 0.25MG BASE, 1MG … · tablet · Cipla LTDSame form
- SiponimodUnited States · 0.25MG, 1MG, 2MG · tablet · DR Reddys Labs LTDSame form
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Siponimod
- Strength
- 1 MG
- Dosage form
- Tablet
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Authorised
- Status in the register
- Approved
- Registration
- DIN 02543370
- Marketing authorisation holder
- Novartis Pharmaceuticals Canada INC
- ATC code
- L04AE03
- Supply
- PRESCRIPTION